Johnson & Johnson
II - In-house lobbyists and trade/business/professional associations
Companies & groups
Johnson & Johnson Plaza, One
New Brunswick, New Jersey 08933
(+1 732)524 0400
15 Leonardo Da Vincilaan
Mr Alex Gorsky
Chairman and CEO
Mr Zeger Vercouteren
Vice President Gov Aff & Pol. EMEA
Johnson & Johnson embraces research and science, bringing innovative ideas, products and services to advance the health and well-being of people. Its family of companies consists of more than 250 operating companies in 57 countries, with products sold for the consumer healthcare, pharmaceutical and medical devices and diagnostics markets.
Cosmetics legislation and policy; selfcare; REACH, RoHs, WEEE, EEE, Medical devices Review, In Vitro Diagnostics Review, Clinical Trials legislation, Falsified Medicines, Transparency legislations, chemicals; environmental initiatives, climate change, Research, competitiveness of industrial sectors, Prevention and lifestyle, Vaccines; IMI2; Trade: CETA, TTIP, EU-Japan, EU India;
Steering Committee EIP-AHA
Pharmaceuticals, Vaccines, Medical devices, Diagnostics, Consumer products, Nutritionals, Cosmetics, Public Health, Innovation, Research and Development, Sustainability, Trade and Tax, Intellectual Property, Consumer Affairs, Sustainability (including environment), Internal Market, Justice and Fundamental Rights
100%: 0 75%: 2 50%: 5 25%: 6
|First name||Surname||Start Date||End Date|
EFPIA, EBE, EVM, Eucomed, AmCham EU/BE, Cosmetics Europe, COCIR, AESGP, Euromcontact, EJF, CSR Europe, EASSI, AIM, EDANA, EDMA, NIA, EPC Global, the EPC, MedTech Europe, BritCham, EPAA
01/2014 - 12/2014
1,750,000 € - 1,999,999 €
No funding received from the EU institutions during the last closed financial year.
By its registration the organisation has signed the Transparency Register Code of Conduct.
The organisation has also declared to be bound to the following other Code:
Internal Johnson&Johnson FCPA and HCBI Guide; EFPIA Code, Eucomed Code, EDMA Code